What happens next in GLP-1 — and when.

Get the briefing

What moved in the GLP‑1 field, in your inbox.

@glp1briefing

What changed › 2026-08-28

Liraglutide, Injection, 6 mg/1 mL (NDC 71288-563-85)

Detected 2026-08-28 in the shortages record for liraglutide, by comparing that day’s fetch against the previous one.

The FDA revises shortage entries in place rather than versioning them, so the reason text on the current record is the only one the public sees. The previous wording is kept here because it is otherwise gone.

What changed

ChangeFieldValue
field_changedreasonEstimated recovery: July 2026

What the record says now

Status
Current
Company
Meitheal Pharmaceuticals, Inc.
Updated
08/27/2026

See liraglutide · the source record.

The previous value above is not recoverable from the source. Both ClinicalTrials.gov and the FDA revise records in place, keeping no public history, which is why this site keeps its own.